114 related articles for article (PubMed ID: 6156971)
21. [Antigen-specific detection and assay of serum HBsAG-AB-immune complexes in HBV carriers (author's transl)].
Tsuji T; Tsuchiya M; Araki K; Shinohara T; Onoe K
Nihon Shokakibyo Gakkai Zasshi; 1980 May; 77(5):806. PubMed ID: 6157039
[No Abstract] [Full Text] [Related]
22. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
[TBL] [Abstract][Full Text] [Related]
23. [Immunoenzyme analysis of antigen-specific determination of HBsAG-containing circulating immune complexes (CIC HBsAG/IgM and CIC HBsAG/IgG) in blood serum of patients with HBV-infection].
Sokolenko AA; Shakhanina KL; Kurilov AN
Biull Eksp Biol Med; 1992 Feb; 113(2):174-6. PubMed ID: 1377044
[TBL] [Abstract][Full Text] [Related]
24. Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody.
Matsumoto A; Imaizumi M; Tanaka Y; Nishiguchi S; Yatsuhashi H; Ishida T; Moriyama K; Aoyagi K; Tanaka E
J Gastroenterol; 2017 Mar; 52(3):376-384. PubMed ID: 27460099
[TBL] [Abstract][Full Text] [Related]
25. Quantification of large and middle proteins of hepatitis B virus surface antigen (HBsAg) as a novel tool for the identification of inactive HBV carriers.
Pfefferkorn M; Böhm S; Schott T; Deichsel D; Bremer CM; Schröder K; Gerlich WH; Glebe D; Berg T; van Bömmel F
Gut; 2018 Nov; 67(11):2045-2053. PubMed ID: 28951526
[TBL] [Abstract][Full Text] [Related]
26. Cell-mediated immune response to liver tissue antigen and hepatitis B surface antigen after infection with hepatitis B virus in humans.
Tiku ML; Beutner KR; Tiku K; Ogra PL
J Infect Dis; 1978 Nov; 138(5):587-96. PubMed ID: 712116
[TBL] [Abstract][Full Text] [Related]
27. Difference of subtypes of hepatitis B surface antigen between asymptomatic carriers and patients with chronic liver diseases.
Nakamura S; Takezawa Y; Maeda T
Tohoku J Exp Med; 1980 Nov; 132(3):367-8. PubMed ID: 6162245
[TBL] [Abstract][Full Text] [Related]
28. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
29. The significance of serologic, histologic, and immunohistologic findings in the prognosis of 88 asymptomatic carriers of hepatitis B surface antigen.
Dormeyer HH; Arnold W; Schönborn H; Braun B; Klinge O; Pfeifer U; Knolle J; Hess G; Kryger P; Nielsen JO; Meyer zum Büschenfelde KH
J Infect Dis; 1981 Jul; 144(1):33-7. PubMed ID: 7264370
[TBL] [Abstract][Full Text] [Related]
30. [Immune response to HBsAg, HBcAg and e-antigen in patients with acute hepatitis and HBsAg carriers with and without liver diseases].
Meyer zum Büschenfelde KH; Arnold W; Knolle J; Hess G
Z Gastroenterol; 1976 May; 14(3):365-77. PubMed ID: 969780
[TBL] [Abstract][Full Text] [Related]
31. The nature and incidence of cryoproteins in hepatitis B antigen (HbsAg) positive patients.
Mcintosh RM; Koss MN; Gocke KJ
Q J Med; 1976 Jan; 45(177):23-38. PubMed ID: 130650
[TBL] [Abstract][Full Text] [Related]
32. Screening for circulating immune complexes in blood donors as an effective method of further HBsAg carriers detection.
Pintera J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(3):455-61. PubMed ID: 6169608
[TBL] [Abstract][Full Text] [Related]
33. Identification of HBsAg determinants in immune complexes from hepatitis B virus-associated vasculitis.
Gupta RC; Kohler PF
J Immunol; 1984 Mar; 132(3):1223-8. PubMed ID: 6198385
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B surface antigen and immunoglobulin M complexes in chronic carriers and patients with acute and chronic liver diseases.
Ayoola EA; Olubuyide I
Afr J Med Med Sci; 1989 Mar; 18(1):21-4. PubMed ID: 2545079
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B surface antigen/IgM complexes: relation to receptors for polymerized human serum albumin, hepatitis B virus (HBV) DNA polymerase activity and HBV markers.
Mora I; Carreño V; Porres JC; Gutiez J; Guio CH
Acta Virol; 1987 Mar; 31(2):116-25. PubMed ID: 2886020
[TBL] [Abstract][Full Text] [Related]
36. [Course control and significance of circulating HBsAg-specific immune complexes in acute viral hepatitis B].
Markus R; Baumgarten R; Fengler JD; Richter H; Apostoloff E
Dtsch Z Verdau Stoffwechselkr; 1986; 46(4):229-42. PubMed ID: 3803280
[TBL] [Abstract][Full Text] [Related]
37. Distinguishing between acute and symptomatic chronic hepatitis B virus infection.
Maruyama T; Schödel F; Iino S; Koike K; Yasuda K; Peterson D; Milich DR
Gastroenterology; 1994 Apr; 106(4):1006-15. PubMed ID: 7511551
[TBL] [Abstract][Full Text] [Related]
38. [The prognostic significance of quantitative HBsAG determination in acute hepatitis B].
Joller-Jemelka HI; Pfister HF; Grob PJ
Schweiz Med Wochenschr; 1985 Sep; 115(37):1249-56. PubMed ID: 3903984
[TBL] [Abstract][Full Text] [Related]
39. Detection of cellular and humoral immunity to hepatitis B surface antigen (HBsAg) in asymptomatic HBsAg carriers.
Sylvan SP; Hellström UB; Lundbergh PR
Clin Exp Immunol; 1985 Nov; 62(2):288-95. PubMed ID: 3878745
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of HBsAg detection in serum of patients with chronic liver disease following removal of circulating immune complexes.
Ackerman Z; Wands JR; Gazitt Y; Brechot C; Kew MC; Shouval D
J Hepatol; 1994 Mar; 20(3):398-404. PubMed ID: 8014453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
